your point about margins is spot on, the number of products can be irrelevant as well.
What I do like about the new products is they are demand driven, rather than being pushed onto the market by AHZ.
We hit the market with the patch. Dr's provide feedback about size/shape. New size and shape sent to market.
Patch is to thick, thinner patch to market.
NEO, 3D are all products designed to fill a demand.
Combine that with the production failure rates that have been addressed in the last 12 months, I am confident the margins are there.
If it is really that good a product then a premium will come with market share.
Probably the best I have felt about AHZ in years. looking forward to HSV2 results. Fingers crossed.
Result Presented Next Week, page-21
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.20 |
Change
-0.550(5.12%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| $10.73 | $10.73 | $10.15 | $109.7K | 10.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 490 | $10.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.20 | 911 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |